Article History
Received: 26 June 2023
Revised: 17 July 2023
Accepted: 24 July 2023
First Online: 29 July 2023
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd. Neither PAK nor JW report any potential conflict of interest.
: No animals or humans were involved in this research.